DIA 2013 49th Annual Meeting
Click here to go to the previous page
Cost Management for Global Drug Development Projects
Track : Track 02: Project/Portfolio Management and Strategic Planning
Program Code: 302
Date: Wednesday, June 26, 2013
Time: 8:00 AM to 9:30 AM  EST
Location: 104C
CHAIR :
 Mark Kryah, (SCHNON), Advisor, Pharmaceutical Project Management, Eli Lilly and Company, United States
SPEAKER (S):
 Mick O'Quigley, MBA (SPKNON), Program Group Leader, Genentech, A Member of the Roche Group, United States
 Carolyn O'Leary, MBA,PMP (SPKNON), Associate Director, Global Project Management, Merck & Co., Inc., United States
 Frank P DePaoli, (SPKNON), Director, Pharmaceutical R&D Advisory Services, PricewaterhouseCoopers LLP, United States
Description
What are the key aspects in developing and managing budgets for drug development projects? How are changes handled? These questions and others, as well as the role of the project manager in cost management, will be explored.